Airsupra Dosing: As-Needed Use Only
Airsupra (albuterol/budesonide) should be used as-needed for symptom relief or prevention of bronchoconstriction, with 2 inhalations per dose, and can be repeated as needed throughout the day—there is no fixed maximum number of times per day, but typical use averages 2-3 doses daily.
Key Dosing Principles
Airsupra is fundamentally different from traditional maintenance inhalers—it is a rescue medication used only when you have symptoms or before anticipated triggers, not on a scheduled basis. Each dose consists of 2 inhalations (delivering 180 μg albuterol + 160 μg budesonide per dose) 1, 2.
Typical Usage Patterns
In the pivotal MANDALA trial with moderate-to-severe asthma patients:
- Mean daily use was approximately 2.6 inhalations per day (about 1.3 doses)
- Most patients used 0-4 inhalations daily on the majority of days
- High daily use (≥8 inhalations/day, or ≥4 doses) was rare
- Extended high use (≥7 consecutive days of high use) was extremely uncommon 1
When to Use Airsupra
Take 2 inhalations:
- When experiencing asthma symptoms (wheezing, shortness of breath, chest tightness, cough)
- Before exercise or known triggers if you anticipate symptoms
- Repeat as needed for symptom relief 3
You can repeat doses throughout the day as symptoms require—the medication was studied and approved for as-needed use without a strict daily maximum 1, 2.
Important Safety Considerations
This is NOT a Daily Scheduled Medication
Unlike traditional budesonide inhalers that require twice-daily scheduled use 4, Airsupra should only be used when needed. Do not use it on a fixed schedule if you have no symptoms.
When High Use Signals a Problem
If you find yourself using ≥8 inhalations per day (≥4 doses) regularly, this indicates poor asthma control and you need to contact your healthcare provider immediately. This pattern suggests:
- Your maintenance therapy may need adjustment
- Your asthma is worsening
- You may be at risk for a severe exacerbation 1
Monitoring Your Use
The MANDALA trial demonstrated that even with as-needed use alongside maintenance ICS therapy, adverse events remained low and comparable to albuterol alone, with no concerning safety signals even in patients who occasionally used higher doses 1.
Clinical Context
The recent BATURA trial in mild asthma showed that as-needed albuterol-budesonide reduced severe exacerbations by 47% compared to albuterol alone, with an annualized exacerbation rate of only 0.15 events per year 3. This demonstrates the medication's effectiveness even with intermittent, as-needed use.
The combination provides:
- Immediate bronchodilation from albuterol (onset within 5 minutes)
- Anti-inflammatory effect from budesonide to address the underlying inflammation
- Reduced risk of severe exacerbations compared to using albuterol alone 2, 3
Common Pitfalls to Avoid
- Don't use it as scheduled maintenance therapy—this wastes medication and isn't how it's designed to work
- Don't delay seeking help if you're using it frequently—increasing rescue inhaler use is a red flag for worsening asthma
- Don't confuse it with your maintenance inhaler—if you're on maintenance therapy, continue that as prescribed
- Don't assume "more is better"—if symptoms aren't improving with repeated doses, seek medical attention rather than continuing to use more 1